Literature DB >> 26768795

Eosinophilic annular erythema: A late but complete response to hydroxychloroquine.

Arzu Karataş Toğral1, Deniz Seçkin1.   

Abstract

A 69-year-old woman with a 12-month history of asymptomatic erythematous, non-scaly, annular and arciform plaques on her face, trunk and extremities is presented. The skin lesions had been unresponsive to treatment with systemic corticosteroids and antihistamines. Skin biopsy demonstrated superficial and deep dermal inflammatory infiltration consisting mainly of eosinophils and a few neutrophils. Dermal interstitial mucin deposition was also detected in the absence of vasculitis, flame figures or granulomatous reaction. The patient was diagnosed as having eosinophilic annular erythema and treated with hydroxychloroquine (2 × 200 mg/day, p.o.). Response to treatment was observed after 7 weeks and full recovery was achieved after 10 weeks. Eosinophilic annular erythema is rarely reported in the literature. Although hydroxychloroquine is a good choice for treatment, response time can vary between patients.
© 2016 The Australasian College of Dermatologists.

Entities:  

Keywords:  annular erythema; eosinophilic annular erythema; hydroxychloroquine

Mesh:

Substances:

Year:  2016        PMID: 26768795     DOI: 10.1111/ajd.12445

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  Steroid Refractory Figurate Eruption with Eosinophilia in a Young Adult Man: A Quiz.

Authors:  Gabriela Żuk; Dominik Samotij; Justyna M Szczęch; Adam Reich
Journal:  Acta Derm Venereol       Date:  2021-05-04       Impact factor: 3.875

2.  Dapsone for Recalcitrant Eosinophilic Annular Erythema: A Case Report and Literature Review.

Authors:  Luke Wallis; Robert C Gilson; Robert T Gilson
Journal:  Dermatol Ther (Heidelb)       Date:  2017-12-08

3.  A case of eosinophilic annular erythema as a presenting sign for autoimmune hepatitis.

Authors:  Olabola Awosika; Kristin Totoraitis; Misty Eleryan; Monica Rengifo-Pardo; Alison Ehrlich
Journal:  JAAD Case Rep       Date:  2017-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.